European Archives - Page 13 of 1191 - European Medical Journal

Dapagliflozin Reverses Cardiac Fibrosis in Diabetic HFpEF, Study Finds

Dapagliflozin reverses myocardial fibrosis in HFpEF with diabetes, suggesting a disease-modifying effect.

Gut Microbiome Predicts Success of Peanut Immunotherapy

Peanut oral immunotherapy (POIT), which involves gradually increasing exposure to peanut protein, has shown promise, successfully desensitising 50–70% of patients.

EAN 2025 Interview: Jana Midelfart-Hoff

The most rewarding aspect is definitely the people you meet on the board. There are so many enthusiastic and extremely competent colleagues…

LHRH Antagonists in Prostate Cancer

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of gonadotropin…

Subclinical Liver Fibrosis Linked to Cardiac Death Risk

Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.

Dr Daejin Adiboye

AbbVie's Dr Daejin Abidoye on community and compassion in cancer care

AbbVie’s Daejin Abidoye reflects on his 20-year journey in oncology – from clinical insights to advances in precision medicine in the cancer space.

GLP-1 Agonists Linked to Lower Dementia and Stroke Risk in Diabetes

Semaglutide and tirzepatide lower risks of dementia, stroke, and death in type 2 diabetes and obesity, new study shows.

World’s Largest Body Scan Study Uncovers Hidden Signs of Disease

UK Biobank’s massive imaging project scans 100,000 people to reveal early disease signs, transforming diagnosis and prevention worldwide.

Unpacking Rare Lung Diseases: Alpha-1 Antitrypsin Deficiency

In the first episode of our Rare Lung Diseases podcast series, host Saranya Ravindran speaks with James Stoller, Cleveland Clinic, about Alpha-1 antitrypsin deficiency, a rare genetic condition that is frequently underdiagnosed.

ICML 2025: Combining Radiation and Bispecific Antibodies in Blood Cancer

A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can be safely integrated with bispecific antibody treatment in patients with relapsed or refractory blood cancers…